SPISANI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 10.465
AS - Asia 5.425
EU - Europa 2.702
SA - Sud America 891
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 19.629
Nazione #
US - Stati Uniti d'America 10.241
SG - Singapore 2.066
CN - Cina 1.413
BR - Brasile 694
VN - Vietnam 634
UA - Ucraina 602
DE - Germania 591
HK - Hong Kong 437
TR - Turchia 342
GB - Regno Unito 330
IT - Italia 262
FI - Finlandia 242
FR - Francia 187
SE - Svezia 157
RU - Federazione Russa 129
MX - Messico 109
IN - India 106
JP - Giappone 104
CA - Canada 87
BD - Bangladesh 71
AR - Argentina 65
ZA - Sudafrica 57
PL - Polonia 53
IQ - Iraq 41
ID - Indonesia 37
ES - Italia 34
PK - Pakistan 29
CO - Colombia 28
BE - Belgio 27
NL - Olanda 27
EC - Ecuador 23
CL - Cile 22
VE - Venezuela 20
PH - Filippine 18
SA - Arabia Saudita 18
LT - Lituania 17
PE - Perù 17
UZ - Uzbekistan 14
MA - Marocco 12
MY - Malesia 12
TN - Tunisia 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
IR - Iran 10
KE - Kenya 10
CZ - Repubblica Ceca 8
IL - Israele 8
JM - Giamaica 7
OM - Oman 7
BO - Bolivia 6
CH - Svizzera 6
DZ - Algeria 6
JO - Giordania 6
CR - Costa Rica 5
EG - Egitto 5
NP - Nepal 5
TH - Thailandia 5
AT - Austria 4
EU - Europa 4
HN - Honduras 4
SN - Senegal 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AU - Australia 3
AZ - Azerbaigian 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
BW - Botswana 2
DK - Danimarca 2
GR - Grecia 2
GT - Guatemala 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 19.609
Città #
Singapore 1.305
Ashburn 1.123
Woodbridge 962
Fairfield 941
Houston 665
Jacksonville 624
Chandler 536
San Jose 518
Ann Arbor 485
Santa Clara 468
Beijing 463
Hong Kong 428
Seattle 363
Wilmington 354
Dallas 315
Cambridge 285
Izmir 196
Munich 190
Ho Chi Minh City 189
Nanjing 184
Los Angeles 171
New York 163
Hanoi 158
Princeton 125
Tokyo 102
Lauterbourg 101
San Diego 94
Helsinki 93
Boardman 88
Milan 83
São Paulo 82
Mexico City 78
Buffalo 74
Shanghai 71
Bremen 61
Ferrara 58
Nanchang 53
Hefei 52
Orem 52
Shenyang 48
Montreal 47
London 46
Warsaw 46
Tianjin 43
Hebei 41
Addison 37
Changsha 35
Dong Ket 33
Johannesburg 33
Chennai 32
Denver 31
Chicago 30
San Mateo 30
Jinan 28
Turku 28
Brooklyn 27
Da Nang 27
The Dalles 27
Atlanta 26
Stockholm 26
Auburn Hills 22
Haiphong 22
Mountain View 22
Poplar 22
Brussels 21
Toronto 21
Jiaxing 20
Frankfurt am Main 19
Phoenix 19
Biên Hòa 18
Hải Dương 18
Rio de Janeiro 18
Manchester 17
Moscow 17
Verona 17
Boston 16
Baghdad 15
Kunming 15
Philadelphia 15
San Francisco 15
Amsterdam 14
Ankara 14
Zhengzhou 14
Augusta 13
Dearborn 13
Dhaka 13
Falkenstein 13
Medellín 13
Tappahannock 13
Bắc Ninh 12
Norwalk 12
Redwood City 12
Brasília 11
Curitiba 11
Tashkent 11
Charlotte 10
Goiânia 10
Guangzhou 10
Mumbai 10
Ningbo 10
Totale 13.682
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 388
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 374
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 338
A cyclic peptide T analogue with high chemotactic activity 283
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 268
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 238
6-(hydroxyphenyl)imidazo[2,1-b]thiazoles as potential antiinflammatory agents: Effects on human neutrophil functions 228
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 221
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 220
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. 217
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 216
Modulation of neutrophil functions by activated platelet release factors 215
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 212
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 210
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 206
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis 206
Ring-opened analogs of indomethacin affecting human neutrophil functions 205
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For‐Hse(Me)‐Leu‐Phe‐OMe 203
Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues 202
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 199
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 199
Attivita' tumoricida dei neutrofili 199
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 198
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 196
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 193
Conformational Aspects of Human Formyl-peptide Receptor Agonists 193
b-peptido sulfonamides. For-Met-Leu-Phe-OMe analogues containing taurine and chiral b-amino-ethansulfonic acid residues 190
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 189
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 188
Conformational aspects of human formylpeptide receptor antagonists 187
Modified chemotactic peptides: Synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe 185
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 183
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 183
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 182
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 180
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 180
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 179
Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety 178
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms 178
An exhaustive insight into the pocket cherge features of the methionine receptor using fMLP analogs. 176
Differences arising in human neutrophil activation passing from N-formyl to N-acetyl-oligopeptides 176
An exhaustive insight into the pocket charge features of the methionine receptor using fMLP analogs. 175
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 175
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 170
Probing structural requirements of fMLP receptor: On the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide 169
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 167
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 166
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 166
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe 165
Oligomeric formylpeptide activity on human neutrophils 165
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 164
HLA B51 antigen associated with neutrophil hyper-reactivity 164
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 162
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 162
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 162
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 160
N-Benzyl-2-chloroindole-3-carboxylic acids as potential anti-inflammatory agents. Synthesis and screening for the effects on human neutrophil functions and on COX1/COX2 activity 160
Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue 158
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 156
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'(methylthio) ethyl] methionine residue 155
2-phenyl-1-arylcarbamoyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 155
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 154
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 154
Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs 154
Synthesis and properties of chemotactic peptide analogs: II. HCO‐Met‐Leu‐Phe‐OMe analogs containing cyclic α,α‐disubstituted amino acids as Met and Phe mimicking residues 154
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 154
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 153
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity 152
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T 152
alfa-Peptide/beta-sulfonamidopeptide hybrids: analogues of the chemotactic agent For-Met-Leu-Phe-OMe; 151
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 151
Protein kinase C mediates human neutrophil cytotoxicity 143
Synthesis and bioactivity of chemotactic tetrapeptides: FMLF-OMe analogues incorporating spacer aminoacids at the lateral positions 143
Pseudopeptides containing the 2-hydrazonoacyl fragment: Analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe 143
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 141
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 140
The importance of the methionine configuration in for-Met-Leu-Phe-OMe biological activities. 139
Antibody-independent cytoxicity against human erythroleukemic K 562 human cells by neutrophils 139
Conformation-activity relationship of peptide t and new pseudocyclic hexapeptide analogs 138
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 138
Valutazione funzionale dei leucociti. 130
FLOW CYTOMETRY STUDY OF CR1, CR3 AND GRANULE CONSTITUENTS IN NEUTROPHILS OF MDS PATIENTS AND HEALTHY CONTROLS: RELATIONSHIP WITH FUNCTIONAL ACTIVITIES AND DISEASE STATES 130
Exploring the interest of 1,2-Dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative 128
Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells 128
Effects of Synthetic Peptides on the Inflammatory Response and Their Therapeutic Potential. 124
Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16 123
Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: The N-terminal region 123
NEW CHEMOTACTIC PEPTIDE ANALOGS WITH HIGH BIOLOGICAL ACTIVITY FOR HUMAN NEUTROPHILS 121
NEUTROPHILS FROM PATIENTS WITH MYELODISPLASTIC SYNDROMES: RELATIONSHIP BETWEEN IMPAIRMENT OF GRANULAR CONTENTS, COMPLEMENT RECEPTORS, FUNCTIONAL ACTIVITIES AND DISEASE STATUS 120
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 119
Chemotactic effects of nociceptin/orphanin FQ on human monocytes are mediated by nop receptor activation 116
Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+ 114
Met-Ile-Phe-Leu derivates: full and partial agonist towards formyl peptide receptors of human neutrophils. 112
Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing ß-alanine or taurine at the central position 112
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 112
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 110
Peptide T revisited: Conformational mimicry of epitopes of anti-HIV proteins 110
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. J.Pept.Sci, 18, 418-426, 2012. 108
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 107
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 106
Totale 17.183
Categoria #
all - tutte 80.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.126
Totale 81.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 0 0 0 0 160 196 92
2021/20221.290 40 162 102 89 61 35 54 64 37 83 144 419
2022/20231.270 132 61 52 153 224 199 62 112 170 7 53 45
2023/2024517 69 66 31 14 27 106 23 51 9 3 4 114
2024/20252.531 67 30 183 72 349 253 138 154 407 274 343 261
2025/20267.129 763 553 704 1.062 1.069 498 730 357 655 738 0 0
Totale 19.735